R&D | January 28, 2026
Eastman & Kolmar Korea join forces to deliver biodegradable beauty breakthroughs
The collaboration will center on expanding access to Eastman’s Esmeri technology
The collaboration will center on expanding access to Eastman’s Esmeri technology
The new functionality complements Parse’s existing Evercode immune products
The approval is grounded in data from a Phase III randomized, double-blind, placebo-controlled, crossover study in NPC patients
In the SHORE phase 3 study, amlitelimab, used in combination with topical therapies, met all primary and key secondary endpoints at Week 24
The approval expands the drug’s existing COPD indication, making it the only single-inhaler triple therapy (SITT) available for both respiratory conditions in China
TruVerus is the only FDA cleared, multi-modal platform capable of delivering comprehensive routine testing from a single lithium heparin sample
This license is a key regulatory milestone in advancing Hester's prevention-led poultry healthcare portfolio
Granules India has reported total income of Rs. 1,384.29 crore during the period ended December 31, 2025
The product delivers 100 percent of the Recommended Dietary Allowance (RDA) of three essential nutrients—Biotin, Vitamin C and Zinc
The research shows 93% of global companies now cover weight-management drugs in their health insurance plans
Subscribe To Our Newsletter & Stay Updated
